BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19751272)

  • 1. The CD4(+)CD8(+) and CD4(+) subsets of FOXP3(+) thymocytes differ in their response to growth factor deprivation or stimulation.
    Lehtoviita A; Rossi LH; Kekäläinen E; Sairanen H; Arstila TP
    Scand J Immunol; 2009 Oct; 70(4):377-83. PubMed ID: 19751272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Bim results in abnormal accumulation of mature CD4-CD8-CD44-CD25- thymocytes.
    Hutcheson J; Perlman H
    Immunobiology; 2007; 212(8):629-36. PubMed ID: 17869640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FOXP3+ subset of human CD4+CD8+ thymocytes is immature and subject to intrathymic selection.
    Tuovinen H; Pekkarinen PT; Rossi LH; Mattila I; Arstila TP
    Immunol Cell Biol; 2008; 86(6):523-9. PubMed ID: 18504453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Regulatory T Cells on Promoting Apoptosis of T Lymphocyte and Its Regulatory Mechanism in Sepsis.
    Luan YY; Yin CF; Qin QH; Dong N; Zhu XM; Sheng ZY; Zhang QH; Yao YM
    J Interferon Cytokine Res; 2015 Dec; 35(12):969-80. PubMed ID: 26309018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Bim by TCR signals in CD4/CD8 double-positive thymocytes.
    Bunin A; Khwaja FW; Kersh GJ
    J Immunol; 2005 Aug; 175(3):1532-9. PubMed ID: 16034091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation.
    Gratiot-Deans J; Ding L; Turka LA; Nuñez G
    J Immunol; 1993 Jul; 151(1):83-91. PubMed ID: 8326141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic and transcriptional analysis supports human regulatory T cell commitment at the CD4+CD8+ thymocyte stage.
    Vanhanen R; Leskinen K; Mattila IP; Saavalainen P; Arstila TP
    Cell Immunol; 2020 Jan; 347():104026. PubMed ID: 31843201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of human thymic regulatory T cells at the double positive stage.
    Nunes-Cabaço H; Caramalho I; Sepúlveda N; Sousa AE
    Eur J Immunol; 2011 Dec; 41(12):3604-14. PubMed ID: 21932449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent thymic origin, differentiation, and turnover of regulatory T cells.
    Mabarrack NH; Turner NL; Mayrhofer G
    J Leukoc Biol; 2008 Nov; 84(5):1287-97. PubMed ID: 18682578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
    Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
    Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ CD31+ recent thymic emigrants in CHD7 haploinsufficiency (CHARGE syndrome): a case.
    Assing K; Nielsen C; Kirchhoff M; Madsen HO; Ryder LP; Fisker N
    Hum Immunol; 2013 Sep; 74(9):1047-50. PubMed ID: 23747993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-step process for thymic regulatory T cell development.
    Lio CW; Hsieh CS
    Immunity; 2008 Jan; 28(1):100-11. PubMed ID: 18199417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCR engagement of CD4+CD8+ thymocytes in vitro induces early aspects of positive selection, but not apoptosis.
    Groves T; Parsons M; Miyamoto NG; Guidos CJ
    J Immunol; 1997 Jan; 158(1):65-75. PubMed ID: 8977176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-7 promotes human regulatory T cell development at the CD4+CD8+ double-positive thymocyte stage.
    Tuulasvaara A; Vanhanen R; Baldauf HM; Puntila J; Arstila TP
    J Leukoc Biol; 2016 Sep; 100(3):491-8. PubMed ID: 26965634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of mouse CD4(+)CD25(+)Foxp3(+) regulatory T cells in xenogeneic pig thymic grafts.
    Zhang B; Zhang A; Qu Y; Liu J; Niu Z; Zhao Y
    Transpl Immunol; 2009 Jan; 20(3):180-5. PubMed ID: 18845256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.
    Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M
    Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP.
    Jiang Q; Su H; Knudsen G; Helms W; Su L
    BMC Immunol; 2006 Apr; 7():6. PubMed ID: 16579866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ CD25+ Foxp3+ IFNγ+ CD178+ human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells.
    Daniel V; Sadeghi M; Wang H; Opelz G
    Hum Immunol; 2013 Feb; 74(2):151-62. PubMed ID: 23017670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The origin of thymic CD4+CD25+ regulatory T cells and their co-stimulatory requirements are determined after elimination of recirculating peripheral CD4+ cells.
    Zhan Y; Bourges D; Dromey JA; Harrison LC; Lew AM
    Int Immunol; 2007 Apr; 19(4):455-63. PubMed ID: 17314081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.